REVVITY, INC. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
As described below, at the annual meeting of shareholders of
Following the approval of the Company's shareholders and effective as of
In connection with the Name Change, the board of directors of the Company
approved an amendment and restatement of the Company's Amended and Restated
By-laws (prior to such amendment and restatement, the "Prior By-laws") to, among
other updates, reflect the Name Change (as amended and restated, the "Amended
and Restated By-laws") effective as of
Item 5.07 Submission of Matters to a Vote of Security Holders.
At the annual meeting of shareholders of the Company held on
• a proposal to elect the nine nominees for director named below for terms
of one year each;
• a proposal to ratify the selection of Deloitte & Touche LLP as the
Company's independent registered public accounting firm for the current
fiscal year;
--------------------------------------------------------------------------------
• a proposal to approve, by non-binding advisory vote, the Company's
executive compensation;
• a proposal to recommend, by non-binding advisory vote, the frequency of
future executive compensation advisory votes; and
• a proposal to amend the Company's restated articles of organization, as
amended, to change the Company's name to "Revvity, Inc. "
The shareholders elected each of the nominees to serve as a director for a term
of one year. The final number of votes cast for or against or abstaining and the
number of broker non-votes for each nominee are listed below. The proposal to
ratify the selection of
In light of the result of the non-binding advisory vote of our shareholders at the annual meeting of shareholders, the Company intends to continue to seek annual non-binding advisory votes on the Company's executive compensation.
--------------------------------------------------------------------------------
Proposal #1 - To elect the following nominees as our directors for terms of one year each: Name Votes in Favor Votes Against Abstentions Broker Non-Votes Peter Barrett, PhD 102,367,661 3,562,139 83,818 6,509,459 Samuel R. Chapin 104,838,554 1,090,624 84,440 6,509,459 Sylvie Grégoire, PharmD 104,244,930 1,632,293 136,395 6,509,459 Michelle McMurray-Heath, MD, PhD 105,569,324 370,740 73,554 6,509,459 Alexis P. Michas 103,442,991 2,413,538 58,514 6,509,459 Prahlad R. Singh, PhD 105,480,309 450,491 82,818 6,509,459 Michael Vounatsos 104,142,844 1,718,229 152,545 6,509,459 Frank Witney, PhD 102,323,514 3,590,126 99,978 6,509,459 Pascale Witz 104,714,460 1,210,436 88,722 6,509,459
Proposal #2 - To ratify the selection of
For Against Abstain Broker Non-Votes 107,124,256 5,254,729 144,092 0
Proposal #3 - To approve, by non-binding advisory vote, the Company's executive
compensation.
For Against Abstain Broker Non-Votes
100,542,538 5,082,669 388,411 6,509,459
Proposal #4 - To recommend, by non-binding advisory vote, the frequency of future executive compensation advisory votes.
1 Year 2 Years 3 Years Abstain Broker Non-Votes 99,492,023 41,009 6,101,017 379,569 6,509,459
Proposal #5 - To approve the amendment of the Company's restated articles of
organization, as amended, to change the name of the Company from "
For Against Abstain Broker Non-Votes 111,054,945 801,605 666,527 0
--------------------------------------------------------------------------------
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
3.1 Articles of Amendment to Amended and Restated Articles of
Organization, as amended.
3.2 Amended and Restated By-laws, redlined for amendments effective
April 26, 2023 .
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
--------------------------------------------------------------------------------
© Edgar Online, source
